CAMBRIDGE, Mass., Sept. 13, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, announced today that on September 7, 2010 the U.S. Patent and Trademark Office issued U.S. Patent No. 7,790,466, entitled “Evaluating Mixtures of Low Molecular Weight Heparins By Chain Profiles or Chain Mapping”. The patent includes claims to methods of analyzing and processing enoxaparin that involve identifying chain sequence information.
